MODERATOR
:
SPEAKER
(S):
Dr. Magali Fontaine, MD, PhD, Director of Transfusion Services, University of Maryland School of Medicine
Dr. Aaron Tobian, MD, PhD, Associate Professor of Pathology, Johns Hopkins University
Current Mitigation Strategies to Prevent Allergic Transfusion Reactions (ATR): the Role of Plasma Removal.,
Dr. William Savage, MD, PhD, Associate Medical Director, Transfusion Medicine, Brigham and Women's Hospital
Donor vs Recipient Factors in the Etiology of Allergic Transfusion Reactions.
Description
Despite the high incidence of allergic transfusion reactions (ATRs), the mechanisms that underlie these reactions are not well described. The program presenters will review the current data on the epidemiology, prevention and mechanisms of ATRs. The presenters will also discuss the role of plasma and the mitigation strategy of plasma removal, the role of donor vs. recipient factors in the etiology of ATR and the characterization of leukocyte and platelet activation markers/signaling pathways that may be activated in patients with a history of ATRs. Strategies targeting these pathways to better prevent ATRs will also be presented.
-
Define leukocyte and platelet activation markers/signaling pathways that may be activated in patients with a history of ATRs.
-
Explain the current mitigation strategies to prevent allergic transfusion reactions and the role of plasma removal.
-
Recognize the role of donor vs. recipient factors in the etiology of allergic transfusion reactions.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.